mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
0.0003 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0004 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
0.19 |
0.0004 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
0.16 |
0.0004 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0004 |
mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |